128 Results for "

epoetin-zeta

" in MedChemExpress (MCE) Product Catalog:
Products (128)

128 Results for "epoetin-zeta" in MCE Product Catalog:

82
82 Publications Verification
Cat. No.: HY-13689
CAS No.: 133053-19-7
Purity:  99.32%
Synonyms: Gö 6983; Goe 6983
Target:  

PKC

Research Areas:  

Cancer

Go 6983 is a pan-PKC inhibitor against for PKCα, PKCβ, PKCγ, PKCδ and PKCζ with IC50 of 7 nM, 7 nM, 6 nM, 10 nM and 60 nM, respectively.
22
22 Cited Publications
Cat. No.: HY-18980
CAS No.: 82-08-6
Synonyms: Mallotoxin; NSC 56346; NSC 94525
Rottlerin, a natural product purified from Mallotus Philippinensis, is a specific PKC inhibitor, with IC50 values for PKCδ of 3-6 μM, PKCα,β,γ of 30-42 μM, PKCε,η,ζ of 80-100 μM. Rottlerin acts as a direct mitochondrial uncoupler, and stimulates autophagy by targeting a signaling cascade upstream of mTORC1. Rottlerin induces apoptosis via caspase 3 activation . Rottlerin inhibits HIV-1 integration and Rabies virus (RABV) infection .
4
4 Cited Publications
Cat. No.: HY-126214
CAS No.: 1361227-90-8
Purity:  99.87%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

JH-RE-06, a potent REV1-REV7 interface inhibitor (IC50=0.78 μM; Kd=0.42 μM), targets REV1 that interacts with the REV7 subunit of POLζ. JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing recruitment of mutagenic POLζ. JH-RE-06 improves chemotherapy .
3
3 Cited Publications
Cat. No.: HY-153343
CAS No.: 2732902-08-6
Purity:  99.92%
Synonyms: BAY 2965501
Target:  

DGK

Research Areas:  

Cancer

BAY 2965501 is a potent and selective diacylglycerol kinase zeta (DGKζ) inhibitor. BAY 2965501 induces pERK activation. BAY 2965501 can be used for the research of cancer .
3
3 Cited Publications
Cat. No.: HY-136179
CAS No.: 873080-25-2
Purity:  99.88%
Target:  

Tyrosinase

Research Areas:  

Inflammation/Immunology

ZAP-180013 is a zeta-chain-associated protein kinase 70 (ZAP-70) inhibitor with an IC50 of 1.8 μM. ZAP-180013 inhibits the interaction of ZAP-70 SH2 domain with immunoreceptor tyrosine-based activation motif (ITAMs) .
3
3 Cited Publications
Cat. No.: HY-123979
CAS No.: 3316-02-7
Purity:  95.05%
Synonyms: NSC37044
Target:  

PKC Apoptosis

Research Areas:  

Cancer

ζ-Stat (NSC37044) is a specific and atypical PKC-ζ inhibitor, with an IC50 of 5 μM. ζ-Stat can reduce melanoma cell lines proliferation and induce apoptosis, and has antitumor activity in vitro .
3
3 Cited Publications
Cat. No.: HY-123979A
CAS No.: 31894-34-5
Purity:  ≥97.0%
Synonyms: NSC37044 trisodium
Target:  

PKC Apoptosis

Research Areas:  

Cancer

ζ-Stat trisodium (NSC37044 trisodium) is a specific and atypical PKC-ζ inhibitor, with an IC50 of 5 μM. ζ-Stat trisodium can reduce melanoma cell lines proliferation and induce apoptosis, and has antitumor activity in vitro .
2
2 Cited Publications
Cat. No.: HY-P1284
CAS No.: 863987-12-6
Target:  

PKC

Research Areas:  

Neurological Disease Cancer

ZIP is a selective peptide inhibitor of PKMζ. ZIP injections can block the impairment in morphine conditioned place preference induced .
2
2 Cited Publications
Cat. No.: HY-P7164
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuEPO; epoetin; EPO
Species:  
Source:  
CHO
2
2 Cited Publications
Cat. No.: HY-P70455
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Interleukin-37; FIL1 zeta; IL-1X; Interleukin-1 Family Member 7; IL-1F7; Interleukin-1 Homolog 4; IL-1H; IL-1H4; Interleukin-1 zeta; IL-1 zeta; Interleukin-1-Related Protein; IL-1RP1; Interleukin-23; IL-37; IL37; FIL1Z; IL1F7; IL1H4; IL1RP1
Species:  
Source:  
2
2 Cited Publications
Cat. No.: HY-122949
CAS No.: 91590-76-0
Purity:  ≥97.0%
Momordicine I is a cucurbitane-type triterpenoids. Momordicine I suppresses glioma growth by promoting apoptosis and impairing mitochondrial oxidative phosphorylation. Momordicine I inhibits glycolysis, lipid metabolism, induces autophagy in HNC cells to suppress head and neck cancer growth. Momordicine I alleviates isoproterenol-induced cardiomyocyte hypertrophy through suppression of PLA2G6 and DGK-ζ. Momordicine I exerts its cardiovascular benefits by upregulating nitric oxide, inhibiting the activity of angiotensin-converting enzyme (ACE), activating the PI3K/Akt pathway, reducing oxidative stress and inflammation. Momordicine I inhibits AKT1, IL-6, and SRC, suggesting its potential application in type 2 diabetes .
1
1 Cited Publications
Cat. No.: HY-149874
CAS No.: 2407854-18-4
Purity:  99.31%
Target:  

DGK

Research Areas:  

Inflammation/Immunology Cancer

BMS-502 (Compound 22) is a potent dual inhibitor of diacylglycerol kinase (DGK) α and ζ with IC50 of 4.6 nM and 2.1 nM. BMS-502 enhanced T cell immune responses in mice. BMS-502 can be used in tumor immunity related research .
1
1 Cited Publications
Cat. No.: HY-P80533
Synonyms: ATGL; Desnutrin; plpl; plpl2; Pnpla2; TTS 2.2; TTS2; TTS2.2; zeta

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human, Mouse, Rat

1
1 Cited Publications
Cat. No.: HY-P86804
Synonyms: 4930549J05Rik antibody; A430104F18Rik antibody; AW552088 antibody; Cd247 antibody; CD3 antibody; CD3 delta antibody; CD3 epsilon antibody; CD3 eta antibody; CD3 gamma antibody; CD3 zeta antibody; CD3H antibody; CD3Q antibody; CD3Z antibody; CD3zeta antibody; Ctg3 antibody; FLJ17620 antibody; FLJ17664 antibody; FLJ18683 antibody; FLJ79544 antibody FLJ94613 antibody; IMD19 antibody; Leu-4 antibody; MGC138597 antibody; OKT3, delta chain antibody; OTTHUMP00000032544 antibody; T cell receptor antibody; T3 antibody; T3d antibody; T3e antibody; T3g antibody; T3z antibody; TCRE antibody; TCRk antibody; Tcrz antibody; TCRzeta antibody

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, IF-Tissue, mIHC

Reactivity:  

Human

Cat. No.: HY-159649
CAS No.: 2618418-12-3
Research Areas:  

Inflammation/Immunology Cancer

BMS-986408 is an orally active inhibitor of DGKα and DGKζ, with IC50 values of 0.0003 μM and 0.002 μM, respectively. BMS-986408 activates intratumoral T cell responses, enhances the priming and expansion of tumor-reactive T cells in tumor-draining lymph nodes, and functions as an immunostimulant. BMS-986408 can be used in the research of tumors .
Cat. No.: HY-115501
CAS No.: 1370281-06-3
Research Areas:  

Cancer

(E)-FOBISIN101 is a 14-3-3 protein-protein interaction (14-3-3 protein-protein interaction) inhibitor, with IC50 values of 9.3 and 16.4 μM for disrupting the binding of 14-3-3ζ or 14-3-3γ to PRAS40, respectively. (E)-FOBISIN101 inhibits the binding of 14-3-3 to Raf-1 and proline-rich AKT substrate, and neutralizes the ability of 14-3-3 to activate exotoxin S ADP-ribosyltransferase. (E)-FOBISIN101 is applicable to 14-3-3-mediated cancer research .
Cat. No.: HY-114134
CAS No.: 122312-54-3
Purity:  ≥95.0%
Synonyms: rhEPO; EPOCH; Genetical recombination

Target:  

Inhibitory Antibodies

Research Areas:  

Metabolic Disease Cancer

Epoetin beta (rhEPO) is a recombinant form of erythropoietin. Epoetin beta is responsible for the maintenance of erythropoiesis and can be used for anaemia research .
Cat. No.: HY-12462
CAS No.: 1421227-52-2
Purity:  98.00%
WS3 is an allosteric inhibitor of 14-3-3 (14-3-3ζ: Kd = 2.29 μM). WS3 activates GSK3β by disrupting the binding of 14-3-3-pGSK3β, promotes the ubiquitination and degradation of NRF2, and inhibits the NRF2-ARE signaling pathway (IC50 = 135 nM). It exerts antioxidant inhibition and chemotherapeutic/ferroptosis sensitizing effects in tumors with hyperactivated NRF2. WS3 binds to EBP1/IKKε and promotes the proliferation of β cells and retinal pigment epithelial (RPE) cells, which can be applied to islet regeneration and RPE expansion transplantation . WS3 is applicable to research related to age-related macular degeneration, retinal degeneration and non-small cell lung cancer .
Cat. No.: HY-153793
CAS No.: 2660218-70-0
Synonyms: DGKζ-IN-1
Research Areas:  

Cancer

Alcudacigib (ASP1570; DGKζ-IN-1) is an orally active diacylglycerol kinase ζ (DGKζ) inhibitor, with an IC50 of 4.7 nM against human DGKζ and an IC50 of 3.0 nM against mouse DGKζ. Alcudacigib selectively inhibits the kinase activity of DGKζ and induces proteasome-dependent degradation of DGKζ protein. Alcudacigib enhances the anti-tumor functions of T cells and NK cells. Alcudacigib can be used for the research of advanced/metastatic solid tumors .
Cat. No.: HY-18713
CAS No.: 1438881-19-6
Target:  

PKC ROCK

CRT0066854 is a potent and selective atypical PKC isoenzymes inhibitor. CRT0066854 is against full-length (FL) PKCι, PKCζ, and ROCK-II kinases with IC50 values of 132 nM, 639 nM, and 620 nM, respectively .